EUVIMEDEUVIMED entdecken
Open Access

Prognostic Factors for Surgically Resected N2 Non-small Cell Lung Cancer

Keishi Kawasaki, Yasunori Sato, Yoshio Suzuki, Haruhisa Saito, Yukihiro Nomura, Yukihiro Yoshida

Annals of Thoracic and Cardiovascular Surgery · 2015 · 21 (3) · 217-222

DOI: 10.5761/atcs.oa.14-00218 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Thoracic and Cardiovascular Surgery, 2015. Verfasst von Keishi Kawasaki und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Asahi General Hospital, Asahi, Chiba, Japan. Hauptthemen laut MEDLINE: Pneumonectomy. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Non-small cell lung cancers (NSCLCs) with pathologically documented ipsilateral mediastinal lymph node (LN) metastases (pN2) are a broad spectrum of diseases. We retrospectively analyzed prognostic factors for cases of pN2 NSCLC treated by surgical resection. METHODS: Clinicopathological data were reviewed for consecutive 121 patients who underwent anatomical pulmonary resection with mediastinal LN sampling or dissection for pN2 NSCLC over a 15-year period. RESULTS: The 5-year survival rate for all patients was 29.9%. Clinical N status, curability, surgical procedure and adjuvant chemotherapy were favorable prognostic factors in univariate analysis, with 5-year survival rates of 35.0% for cN0/1 vs. 17.7% for cN2/3 cases; 33.1% for R0 vs. 14.7% for R1/2 resection; 31.5% for lobectomy vs. 25.0% for bilobectomy and 15.6% for pneumonectomy; and 72.7% with adjuvant chemotherapy vs. 23.8% without adjuvant chemotherapy. Survival did not differ significantly based on gender, age, smoking status, clinical T status, tumor location, histology, skip metastasis, subcarinal LN metastasis, or number of involved N2 levels. In multivariate analysis, adjuvant chemotherapy, R0 resection, and lobectomy emerged as independent favorable prognostic factors. CONCLUSION: Complete resection using lobectomy and adjuvant chemotherapy are favorable prognostic factors in cases of pN2 NSCLC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PneumonectomyAgedCarcinoma, Non-Small-Cell LungChemotherapy, AdjuvantFemaleHumansKaplan-Meier EstimateLung NeoplasmsLymph Node ExcisionLymphatic MetastasisMaleMultivariate AnalysisNeoplasm StagingNeoplasm, ResidualProportional Hazards ModelsRetrospective StudiesRisk FactorsTime FactorsTreatment Outcome

Autor:innen und Institutionen

  • Department of Surgery, Asahi General Hospital, Asahi, Chiba, Japan.

Zitieren

APA

Kawasaki, K., Sato, Y., Suzuki, Y., Saito, H., Nomura, Y., & Yoshida, Y. (2015). Prognostic Factors for Surgically Resected N2 Non-small Cell Lung Cancer. Annals of Thoracic and Cardiovascular Surgery, 21(3), 217-222. https://doi.org/10.5761/atcs.oa.14-00218

Vancouver

Kawasaki K, Sato Y, Suzuki Y, Saito H, Nomura Y, Yoshida Y. Prognostic Factors for Surgically Resected N2 Non-small Cell Lung Cancer. Annals of Thoracic and Cardiovascular Surgery. 2015;21(3):217-222. doi:10.5761/atcs.oa.14-00218

BibTeX
@article{Kawasaki2015,
  author = {Kawasaki, Keishi and Sato, Yasunori and Suzuki, Yoshio and Saito, Haruhisa and Nomura, Yukihiro and Yoshida, Yukihiro},
  title = {Prognostic Factors for Surgically Resected N2 Non-small Cell Lung Cancer},
  journal = {Annals of Thoracic and Cardiovascular Surgery},
  year = {2015},
  volume = {21},
  number = {3},
  pages = {217--222},
  doi = {10.5761/atcs.oa.14-00218}
}
Kostenlos starten →